Stay updated on PD-1 and Cell Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PD-1 and Cell Therapy in NSCLC Clinical Trial page.
Latest updates to the PD-1 and Cell Therapy in NSCLC Clinical Trial page
- Check4 days agoChange DetectedFooter now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed. This does not alter the study content, eligibility criteria, outcomes, or how users interact with the page.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 appears on the page, indicating a UI/version update. This does not alter study details, eligibility criteria, or other substantive information on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check41 days agoChange DetectedDeleted the site-wide government funding status and NIH operation notice from the page. The study details and related information remain unchanged.SummaryDifference0.4%
- Check55 days agoChange DetectedThe page shows minor administrative updates, including a refreshed last update date and light formatting changes. Core study details and eligibility remain unchanged.SummaryDifference0.5%
- Check83 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%
- Check90 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
Stay in the know with updates to PD-1 and Cell Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and Cell Therapy in NSCLC Clinical Trial page.